Investors
Corporate Profile
Genetron Holdings Limited (“Genetron Health” or the “Company”) is a leading precision oncology platform company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care.
Latest Quarterly Results
News Releases
2/9/2021
1/27/2021
1/13/2021
Events & Presentations
11/19/2020 at 8:30 AM EST
11/09/2020 at 8:30 AM EST
SEC Filings
Filing date | Form | Description | View |
---|---|---|---|
424B4 | Form of prospectus disclosing information facts events covered in both forms 424B1 424B3 |
View HTML | |
6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act |
View HTML | |
6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act |
View HTML |